T1	Treatment 275 293	oral contraceptive
T2	Treatment 326 344	clomiphene citrate
T3	Treatment 507 753	prospectively to either group 1 (oral contraceptive/clomiphene citrate), which received continuous oral contraceptives followed by clomiphene citrate, or to group 2 (control) received no treatment in the cycle before clomiphene citrate treatment.
T4	Treatment 754 888	On day 3, 17 beta-estradiol, follicle-stimulating hormone, luteinizing hormone, and androgens were assayed before and after treatment.
T5	Treatment 1543 1562	clomiphene citrate.
